z-logo
open-access-imgOpen Access
Apalutamide compared with darolutamide for the treatment of non-metastatic castration resistant prostate cancer: efficacy and tolerability in a matching-adjusted indirect comparison
Author(s) -
Simon Chowdhury,
С. Оудард,
Hiroji Uemura,
Steven Joniau,
Lindsay Dearden,
C. Capone,
Suzy Van Sanden,
Joris Diels,
Boris Hadaschik
Publication year - 2022
Publication title -
onkourologiâ
Language(s) - English
Resource type - Journals
eISSN - 1996-1812
pISSN - 1726-9776
DOI - 10.17650/1726-9776-2022-18-1-77-89
Subject(s) - medicine , prostate cancer , tolerability , oncology , urology , cancer , adverse effect

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here